These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 17710346)

  • 1. [Distortion product otoacoustic emissions in infants from birth to two months].
    Pinto VS; Lewis DR
    Pro Fono; 2007; 19(2):195-204. PubMed ID: 17710346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of neonatal hearing impairment: evaluation of transient evoked otoacoustic emission, distortion product otoacoustic emission, and auditory brain stem response test performance.
    Norton SJ; Gorga MP; Widen JE; Folsom RC; Sininger Y; Cone-Wesson B; Vohr BR; Mascher K; Fletcher K
    Ear Hear; 2000 Oct; 21(5):508-28. PubMed ID: 11059707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of common stimulus parameters on distortion product otoacoustic emission fine structure.
    Johnson TA; Baranowski LG
    Ear Hear; 2012; 33(2):239-49. PubMed ID: 21918451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of neonatal hearing impairment: distortion product otoacoustic emissions during the perinatal period.
    Gorga MP; Norton SJ; Sininger YS; Cone-Wesson B; Folsom RC; Vohr BR; Widen JE; Neely ST
    Ear Hear; 2000 Oct; 21(5):400-24. PubMed ID: 11059701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Test-retest repeatability of distortion product otoacoustic emissions.
    Wagner W; Heppelmann G; Vonthein R; Zenner HP
    Ear Hear; 2008 Jun; 29(3):378-91. PubMed ID: 18382378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distortion product otoacoustic emission test performance for a priori criteria and for multifrequency audiometric standards.
    Gorga MP; Neely ST; Dorn PA
    Ear Hear; 1999 Aug; 20(4):345-62. PubMed ID: 10466570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of hearing loss using 2f2-f1 and 2f1-f2 distortion-product otoacoustic emissions.
    Fitzgerald TS; Prieve BA
    J Speech Lang Hear Res; 2005 Oct; 48(5):1165-86. PubMed ID: 16411804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal Development of Distortion Product Otoacoustic Emissions in Infants With Normal Hearing.
    Hunter LL; Blankenship CM; Keefe DH; Feeney MP; Brown DK; McCune A; Fitzpatrick DF; Lin L
    Ear Hear; 2018; 39(5):863-873. PubMed ID: 29369290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of Minor Conductive Hearing Loss in Humans Using Distortion Product Otoacoustic Emissions.
    Marcrum SC; Kummer P; Steffens T
    Ear Hear; 2017; 38(4):391-398. PubMed ID: 28169838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distortion-product otoacoustic emission growth curves in neonates.
    Barbosa TA; Durante AS; Granato L
    Rev Assoc Med Bras (1992); 2014; 60(6):591-8. PubMed ID: 25650862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fine structure of distortion product otoacoustic emissions: its dependence on age and hearing threshold and clinical implications.
    Wagner W; Plinkert PK; Vonthein R; Plontke SK
    Eur Arch Otorhinolaryngol; 2008 Oct; 265(10):1165-72. PubMed ID: 18301908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of inner ear hearing loss on delayed otoacoustic emissions (TEOAE) and distortion products (DPOAE)].
    Hoth S
    Laryngorhinootologie; 1996 Dec; 75(12):709-18. PubMed ID: 9081275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.
    Reavis KM; Phillips DS; Fausti SA; Gordon JS; Helt WJ; Wilmington D; Bratt GW; Konrad-Martin D
    Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distortion product otoacoustic emission test performance when both 2f1-f2 and 2f2-f1 are used to predict auditory status.
    Gorga MP; Nelson K; Davis T; Dorn PA; Neely ST
    J Acoust Soc Am; 2000 Apr; 107(4):2128-35. PubMed ID: 10790038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distortion-product otoacoustic emissions in middle-aged subjects with normal versus potentially presbyacusic high-frequency hearing loss.
    Nieschalk M; Hustert B; Stoll W
    Audiology; 1998; 37(2):83-99. PubMed ID: 9547922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity of distortion-product otoacoustic emissions in humans to tonal over-exposure: time course of recovery and effects of lowering L2.
    Sutton LA; Lonsbury-Martin BL; Martin GK; Whitehead ML
    Hear Res; 1994 May; 75(1-2):161-74. PubMed ID: 8071143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical test performance of distortion-product otoacoustic emissions using new stimulus conditions.
    Johnson TA; Neely ST; Kopun JG; Dierking DM; Tan H; Gorga MP
    Ear Hear; 2010 Feb; 31(1):74-83. PubMed ID: 19701088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dependence of distortion-product otoacoustic emissions on primary levels in normal and impaired ears. I. Effects of decreasing L2 below L1.
    Whitehead ML; McCoy MJ; Lonsbury-Martin BL; Martin GK
    J Acoust Soc Am; 1995 Apr; 97(4):2346-58. PubMed ID: 7714254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distortion product otoacoustic emissions measured as vibration on the eardrum of human subjects.
    Dalhoff E; Turcanu D; Zenner HP; Gummer AW
    Proc Natl Acad Sci U S A; 2007 Jan; 104(5):1546-51. PubMed ID: 17242353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeatability of high-frequency distortion-product otoacoustic emissions in normal-hearing adults.
    Dreisbach LE; Long KM; Lees SE
    Ear Hear; 2006 Oct; 27(5):466-79. PubMed ID: 16957498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.